Entasis Therap
1 products tracked · names used in filings: Entasis Therap
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 12 Dec 2025🇺🇸 FDA approval
FDA approves Nuzolvence (zoliflodacin), a new medicine
Entasis Therap; NDA219491; New molecular entity, Priority review; for suspension · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Nuzolvence zoliflodacin | Approved | 2025-12-12 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.